EP0824586A4 - Uridine diphosphate galactose-4-epimerase humaine - Google Patents

Uridine diphosphate galactose-4-epimerase humaine

Info

Publication number
EP0824586A4
EP0824586A4 EP95920385A EP95920385A EP0824586A4 EP 0824586 A4 EP0824586 A4 EP 0824586A4 EP 95920385 A EP95920385 A EP 95920385A EP 95920385 A EP95920385 A EP 95920385A EP 0824586 A4 EP0824586 A4 EP 0824586A4
Authority
EP
European Patent Office
Prior art keywords
epimerase
uridine diphosphate
diphosphate galactose
human uridine
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95920385A
Other languages
German (de)
English (en)
Other versions
EP0824586A1 (fr
Inventor
Hongjun Ji
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0824586A1 publication Critical patent/EP0824586A1/fr
Publication of EP0824586A4 publication Critical patent/EP0824586A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP95920385A 1995-05-11 1995-05-11 Uridine diphosphate galactose-4-epimerase humaine Withdrawn EP0824586A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002219770A CA2219770A1 (fr) 1995-05-11 1995-05-11 Uridine diphosphate galactose-4-epimerase humaine
PCT/US1995/005785 WO1996035778A1 (fr) 1995-05-11 1995-05-11 Uridine diphosphate galactose-4-epimerase humaine

Publications (2)

Publication Number Publication Date
EP0824586A1 EP0824586A1 (fr) 1998-02-25
EP0824586A4 true EP0824586A4 (fr) 2001-12-05

Family

ID=25679781

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95920385A Withdrawn EP0824586A4 (fr) 1995-05-11 1995-05-11 Uridine diphosphate galactose-4-epimerase humaine

Country Status (3)

Country Link
EP (1) EP0824586A4 (fr)
CA (1) CA2219770A1 (fr)
WO (1) WO1996035778A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232066B1 (en) * 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
US6238869B1 (en) * 1997-12-19 2001-05-29 High Throughput Genomics, Inc. High throughput assay system

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BAUER A J ET AL: "THE ISOLATION PURIFICATION AND PRELIMINARY CRYSTALLOGRAPHIC CHARACTERIZATION OF UDP-GALACTOSE-4-EPIMERASE FROM ESCHERICHIA-COLI", PROTEINS STRUCTURE FUNCTION AND GENETICS, vol. 9, no. 2, 1991, pages 135 - 142, XP001012852, ISSN: 0887-3585 *
BEUTLER E: "GALACTOSEMIA: SCREENING AND DIAGNOSIS", CLINICAL BIOCHEMISTRY, PERGAMON PRESS, XX, vol. 24, no. 4, August 1991 (1991-08-01), pages 293 - 300, XP001006991, ISSN: 0009-9120 *
DAUDE N ET AL: "MOLECULAR CLONING, CHARACTERIZATION, AND MAPPING OF A FULL-LENGTH CDNA ENCODING HUMAN UDP-GALACTOSE 4'-EPIMERASE", BIOCHEMICAL AND MOLECULAR MEDICINE, ORLANDO, FL, US, vol. 56, no. 1, October 1995 (1995-10-01), pages 1 - 7, XP001017809, ISSN: 1077-3150 *
ENDRES W ET AL: "CATARACT AND METABOLIC DISEASE", JOURNAL OF INHERITED METABOLIC DISEASE, vol. 13, no. 4, 1990, pages 509 - 516, XP001018227, ISSN: 0141-8955 *
See also references of WO9635778A1 *
ZESCHNIGK M ET AL: "CDNA FROM RAT CELLS WITH RECONSTITUTIVE GALACTOSE-EPIMERASE ACTIVITY IN E. COLI", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 18, no. 17, 1990, pages 5289, XP000999390, ISSN: 0305-1048 *

Also Published As

Publication number Publication date
WO1996035778A1 (fr) 1996-11-14
CA2219770A1 (fr) 1996-11-14
EP0824586A1 (fr) 1998-02-25

Similar Documents

Publication Publication Date Title
GB9413724D0 (en) Therapeutic nucleosides
GB2304397B (en) Joystick
EP0865368A4 (fr) Structure cycliquement mobile pour contact au sol
PL324346A1 (en) Macrolides
GB9508646D0 (en) Lisa
EP0824586A4 (fr) Uridine diphosphate galactose-4-epimerase humaine
GB9514268D0 (en) Pyrimidine nucleoside
AU2585295A (en) Human uridine diphosphate galactose-4-epimerase
EP0815199A4 (fr) Desoxycytidine kinase 2 humaine
HU9501541D0 (en) Cultivator
CA76875S (en) Harrow
GB9504253D0 (en) Study system
PL103800U1 (en) Power-lift-mounted deep-tillage plough
HU791U (en) Plough
GB9509493D0 (en) Multi-share plough
AU131466S (en) Hoe
PL57468Y1 (en) Weeder
AU1105P (en) DALESE Metrosideros excelsus
GB9502962D0 (en) Diagnostic technique
GB9502965D0 (en) Diagnostic technique
ZA969658B (en) Cyclically moveable ground-engaging structure
GB9516623D0 (en) Cryonator or cryotory
GB9506161D0 (en) Medical aid
GB9517973D0 (en) Disposable rainwear
GB9508039D0 (en) Continuous sterilisation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971209

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20011022

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020626

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030820